Ranibizumab for Macular Edema Secondary to Central and Branch Retinal Vein Occlusion in Patients Younger Than 50 Years of Age

BACKGROUND: To determine the effectiveness of intravitreal ranibizumab (IVR) approach over 1-year follow-up in patients younger than 50 years old with central and branch retinal vein occlusion (RVO) complicated by macular edema (ME). METHODS: Prospective, open-label case series. Patients initiating...

Descripción completa

Detalles Bibliográficos
Autores principales: Battaglia Parodi, Maurizio, Romano, Francesco, Arrigo, Alessandro, Mercuri, Stefano, Franceschi, Alessandro, Bandello, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320288/
https://www.ncbi.nlm.nih.gov/pubmed/32685489
http://dx.doi.org/10.1155/2020/4747696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320288/
https://www.ncbi.nlm.nih.gov/pubmed/32685489
http://dx.doi.org/10.1155/2020/4747696

Ejemplares similares